Covered recipient · General Payments record
PETER KARTH
Allopathic & Osteopathic Physicians Ophthalmology Retina Specialist
General Payments · PY2018–2024
$120,468.92
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,400.00 | 3 |
| Food and Beverage | $715.97 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $5,506.00 | 4 |
| ABBVIE INC. | $278.76 | 14 |
| GLAUKOS CORPORATION | $121.30 | 1 |
| Regeneron Healthcare Solutions, Inc. | $74.40 | 2 |
| Genentech USA, Inc. | $62.94 | 3 |
| Apellis Pharmaceuticals, Inc. | $24.97 | 1 |
| Alimera Sciences, Inc. | $24.68 | 1 |
| Astellas Pharma US Inc | $22.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.76 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035311 | CMS |
| ABBVIE INC. | $24.90 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035313 | CMS |
| ABBVIE INC. | $24.81 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035315 | CMS |
| ABBVIE INC. | $3.56 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035317 | CMS |
| ABBVIE INC. | $11.97 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035319 | CMS |
| ABBVIE INC. | $26.79 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035321 | CMS |
| ABBVIE INC. | $23.34 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035323 | CMS |
| ABBVIE INC. | $25.18 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035325 | CMS |
| ABBVIE INC. | $25.86 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035327 | CMS |
| ABBVIE INC. | $23.50 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035329 | CMS |
| ABBVIE INC. | $5.41 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035331 | CMS |
| ABBVIE INC. | $23.11 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035333 | CMS |
| ABBVIE INC. | $6.02 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035335 | CMS |
| ABBVIE INC. | $25.55 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104035337 | CMS |
| Alcon Vision LLC | $700.00 | 02/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110527693 | CMS |
| Alcon Vision LLC | $700.00 | 02/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110527695 | CMS |
| Alcon Vision LLC | $4,000.00 | 05/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110527697 | CMS |
| Alcon Vision LLC | $106.00 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110671351 | CMS |
| Alimera Sciences, Inc. | $24.68 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092825428 | CMS |
| Apellis Pharmaceuticals, Inc. | $24.97 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154027625 | CMS |
| Astellas Pharma US Inc | $22.92 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139380390 | CMS |
| Genentech USA, Inc. | $22.29 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133088125 | CMS |
| Genentech USA, Inc. | $22.36 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133088129 | CMS |
| Genentech USA, Inc. | $18.29 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133088133 | CMS |
| Glaukos Corporation | $121.30 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151978204 | CMS |
| Regeneron Healthcare Solutions, Inc. | $34.42 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114082575 | CMS |
| Regeneron Healthcare Solutions, Inc. | $39.98 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114082577 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.